107.522 articles found

Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson's disease

ROYLANCE H H BILL.

· 2001-11-21

Parkinson's disease.

Constantino AE, Honig LS.

Sci Aging Knowledge Environ · 2001-11-14

DOI: 10.1126/sageke.2001.7.dn4PMID: 14602969

Method of treating Parkinson's disease

SVENSSON KJELL A.

· 2001-11-13

Use of tetracyclines as neuro-protective agents and for the treatment of parkinson's disease and related disorders

DU YANSHENG, DODEL RICHARD.

· 2001-11-13

New 2-amino-4-(pyridylmethyl) thiazoline derivatives having inducible NO-synthase inhibiting activity, useful for treating of Parkinson's disease, cerebral disorders, migraines, depression, diabetes

BACQUE ERIC, BIGOT ANTONY, CARRY JEAN CHRISTOPHE, MIGNANI SERGE, RONAN BAPTISTE, TABART MICHEL.

· 2001-11-09

New 2-amino-4-(heteroarylethyl) thiazoline derivatives having inducible NO-synthase inhibiting activity, useful for treating Parkinson's, cerebral disorders, migraines, depression, diabetes

BACQUE ERIC, BIGOT ANTONY, CARRY JEAN CHRISTOPHE, MIGNANI SERGE.

· 2001-11-09

New 2-amino-thiazoline derivatives having inducible NO-synthase inhibiting activity, useful for treating Parkinson's, cerebral disorders, migraines, depression, diabetes

BIGOT ANTONY, CARRY JEAN CHRISTOPHE, MIGNANI SERGE.

· 2001-11-09

ANTIBODY PTI-HS7 FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES AND PARKINSON'S DISEASE

CASTILLO GERARDO, CHOI PAULA Y, CUMMINGS JOEL A, SNOW ALAN D.

· 2001-11-02

Antibody PTI-HS7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease

CASTILLO GERARDO, CHOI PAULA Y, CUMMINGS JOEL A, SNOW ALAN D.

· 2001-11-02

CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.

Hidestrand M, Oscarson M, Salonen JS, Nyman L, Pelkonen O, Turpeinen M, Ingelman-Sundberg M.

Drug Metab Dispos · 2001-11-01

PMID: 11602525

Videodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy.

Fowler CJ.

J Neurol Neurosurg Psychiatry · 2001-11-01

DOI: 10.1136/jnnp.71.5.575PMID: 11606663

Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy.

Sakakibara R, Hattori T, Uchiyama T, Yamanishi T.

J Neurol Neurosurg Psychiatry · 2001-11-01

DOI: 10.1136/jnnp.71.5.600PMID: 11606669